1) Omeprazole works differently, inhibiting the enzyme that pumps acid out of gut cells regardless of what stimulates acid production.

2) It therefore seems justified to recommend amoxicillin/omeprazole as the treatment of choice to eradicate H pylori in H pylori related gastroduodenal diseases.

3) At low doses of omeprazole doctors believe they can avoid any danger of cancer.

4) Glaxo's scientists say omeprazole should be used sparingly because it might cause cancer.

5) Our observation that short term treatment with omeprazole increases serum pepsinogen A and C levels confirms previous studies.

6) Omeprazole monotherapy merely suppressed bacterial colonisation, especially in the antral region, and eradicated H pylori in individual cases only.

7) Oesophagitis was treated with omeprazole 40 mg/day for a median duration of 12 weeks.

8) OBJECTIVE : To objectively evaluate the domestic omeprazole Aoke.

9) OBJECTIVE To develop the enteric coated omeprazole pellets.

10) Suggest metabolites for the proton pump inhibitor Omeprazole.

11) OBJECTIVE To study the pharmacokinetics of omeprazole ( OME ) in 8 patients with liver cirrhosis.

12) Results The total efficiencies of omeprazole and famotidine 100 % and %, respectively.

13) Conclusions The effect of 2 weeks omeprazole triple therapy is much better than tagamet triple therapy in DU. But HP eradicate rate is samilar in the two groups.

14) And in Group II we treat them with omeprazole ( 20 mg , Po , bid ,() 3 weeks ).

15) In control group, Omeprazole was applied alone. The efficacy was assessed according to the improvement of symptoms and the repair of the mucosal lesion under gastroscopic examination.

16) Methods: The efficacy of omeprazole and famotidine in treating 82 duodenal ulcer patients were analysed.

17) Omeprazole stimulates liver regeneration after reduced - size liver transplantation and this regeneration may be mediated by gastrin.

18) High values of serum pepsinogen A have also been found during omeprazole treatment.

19) The recurrence rate was similar to that reported after two years' treatment with omeprazole.

20) As a result of these findings Glaxo stopped clinical trials comparing ranitidine with omeprazole for ethical reasons.

21) Objective To study the relative bioavailability and bioequivalence of omeprazole Enteric - coated capsules in healthy volunteers.

22) Esomeprazole, a new proton pump inhibitor, is the S - isomer of omeprazole.

23) Conclusions The incidence of mental confusion in postoperative elderly patients was correlative with age, cerebral infarction and administration of omeprazole and compound amino- acid.

24) Rabeprazole is second - generation product of proton pump inhibitors ( PPIs ) after the producing of Omeprazole and Lanprazole.

25) Objective To study the relative bioavailability and bioequivalence of omeprazole enteric-coated capsules in healthy volunteers.

26) AIM: To observe the eradicative effect of dioctahedral smectite (DS) combined with omeprazole on Helicobacter pylori (HP) and its efficacy in treatment of peptic ulcer.

27) Objective: To establish an HPLC method for the determination of the concentrations of omeprazole and lansoprazole in plasma.

28) Near infrared diffuse reflectance spectroscopy applied to determine the water content in omeprazole sodium for injection.

29) Objective To establish a RP - HPLC method for the determination of content of omeprazole.

30) Methods: 60 cases were selected and divided randomly into control group and treatment group, the latter by bigeminy therapy with the decoction and Omeprazole ECT,[http:///omeprazole.html] the former by Omeprazole ECT only.

31) Conclusion Omeprazole combined with sucralfate is an effective method to prevent upper gastrointestinal rebleeding in liver cirrhosis with hepatitis B.

32) METHODS: Esomeprazole and omeprazole for treatment and maintenance treatment of reflux oesophagitis was analyzed by using the cost-effectiveness analytical method.